6Ekhart C,Rodenhuis S,Smits P H,et al.An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment[J].Cancer Treat Rev,2009,35(1):18-31.
7Lyseng-Williamson K A,Fenton C.Taxanes for the adjuvant treatment of early breast cancer:systematic review and economic evaluation[J].Health Technol Assess,2007,11(40):1-144.
8Herceq D,Vrbanec D.The role of taxanes in breast cancer chemotherapy:what' s new 15 years after[J].Lijec Vjesn,2009,131(5-6):133-141.
9Nabholtz,Jcan-Marc,Gligorov,et al.The role of taxanes in the treatment of breast[J].Expe Opin Phar,2005,6(7):1073-1094.
10Noguchi S.Predictive factors for response to docetaxel in human breast cancers[J].Cancer Sci,2006,97(9):813-20.
